Review
doi: 10.1016/0033-0620(77)90022-6.
Clinical pharmacokinetics of antiarrhythmic drugs
- PMID: 335439
- DOI: 10.1016/0033-0620(77)90022-6
Item in Clipboard
Review
Clinical pharmacokinetics of antiarrhythmic drugs
Prog Cardiovasc Dis.
1977 Nov-Dec.
No abstract available
Similar articles
-
Clinical pharmacology of antiarrhythmic drugs: a review and overview, part II.Int J Clin Pharmacol Ther Toxicol. 1981 May;19(5):185-99. Int J Clin Pharmacol Ther Toxicol. 1981. PMID: 6788721 No abstract available.
-
Metabolites of antiarrhythmic drugs: are they clinically important?Ration Drug Ther. 1986 May;20(5):1-5. Ration Drug Ther. 1986. PMID: 3097754 No abstract available.
-
Antiarrhythmic drugs: clinical pharmacology and therapeutic uses.Drugs. 1978 Apr;15(4):271-309. doi: 10.2165/00003495-197815040-00003. Drugs. 1978. PMID: 648399 No abstract available.
-
[Pharmacokinetics of the principal anti-arrhythmia agents].Coeur Med Interne. 1978 Jan-Mar;17(1):79-88. Coeur Med Interne. 1978. PMID: 25160 Review. French. No abstract available.
-
The role of antiarrhythmic drugs in prevention of sudden cardiac death.Cardiovasc Clin. 1985;15(3):265-86. Cardiovasc Clin. 1985. PMID: 2421903 Review. No abstract available.
Cited by
-
Role of concentration-dependent plasma protein binding in disopyramide disposition.J Pharmacokinet Biopharm. 1979 Feb;7(1):29-46. doi: 10.1007/BF01059439. J Pharmacokinet Biopharm. 1979. PMID: 458555 No abstract available.
-
Bioavailability and saturation of the presystemic metabolism of oral lorcainide therapy initiated in three different dose regimens.Eur J Clin Pharmacol. 1983;24(4):517-9. doi: 10.1007/BF00609895. Eur J Clin Pharmacol. 1983. PMID: 6861866 Clinical Trial.
-
Mexiletine: a review of its pharmacological properties and therapeutic efficacy in arrhythmias.Drugs. 1979 Mar;17(3):161-81. doi: 10.2165/00003495-197917030-00003. Drugs. 1979. PMID: 378646 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
